Operating Margin

DHT Holdings sells two older tankers for $101.6M, securing a major cash injection. The move highlights a strategy of fleet renewal and shareholder value.

Indonesia's Mowilex marks seven years of verified carbon neutrality, pivoting from certificates to permanent infrastructure with major solar power investments.

Croatian firm Orqa is building a global network to produce one million drones annually, challenging market leaders and securing allied defense supply chains.

Medical cannabis firm Crucial Innovations retains FOCUS Capital Partners, signaling a push for institutional investment and a potential 2026 US listing.

The 2025 Governors' Awards reveal how historic sites are being transformed into hubs for social housing, Reconciliation, and economic growth across Canada.

Avantor appoints financial heavyweight Simon Dingemans to its board, a strategic move to accelerate its ambitious turnaround amid market pressures.

Pharma giant GSK partners with biotech CAMP4, leveraging novel RNA-boosting tech to develop new therapies for neurodegenerative and kidney diseases.

A €2.3M grant will help an Irish consortium develop advanced liquid cooling, tackling the immense energy demands of data centers and electric vehicles.

SCALE AI's record funding fuels 44 new projects, aiming to accelerate homegrown AI and secure Canada's digital future amid fierce global competition.

The crypto giant reports massive growth, but a pivot to AI, operational fires, and rising debt reveal a risky strategy to reshape global computing power.

As New Jersey's cannabis market booms, Grown Rogue's one-year success reveals a potent strategy for blending craft quality with low-cost execution.

Sectra posts record profits, but a costly cloud transition and security delays test its strategy. Is this the price of future leadership in AI healthcare?

Genmab's $8 billion acquisition of Merus isn't just a deal; it's a bold strategy to own its destiny and dominate the future of oncology therapeutics.

Lument Finance Trust's latest dividend boasts an attractive yield, but recent adjustments raise questions about the health of commercial real estate.

BrightView Holdings declared its eighth straight cash dividend, a move signaling financial discipline even as it navigates revenue challenges and stock volatility.

A routine filing reveals a major strategic play. See how BridgeBio Oncology uses special equity grants to attract top minds in the fierce race for a cancer cure.

KBRA rates a $328M mortgage trust with significant 'non-prime' loans, signaling a boom in a market segment that balances risk with investor demand.

A key industry award for tech partner CI&T reveals how AI and data are the new foundations of high-end retail. Who is building the future of luxury?

Inotiv partners with AI firm VUGENE, but this is no simple tech deal. It's a high-stakes move to compete in a market dominated by AI-powered giants.

Estonia's top utility secures key financing for a massive infrastructure upgrade. We decode the risks, rewards, and long-term impact for investors.